Naturally occurring regulatory CD4 ϩ
. Consequently, FOXP3-deficient recombinant mice or the natural mutant scurfy exhibit an analogous immune pathology due to a lack of regulatory T cells that are able to actively suppress immune responses against self antigens [1] [2] [3] . In agreement, FOXP3 expression is found in Treg cells with the onset of their development in thymus.
FOXP3, a member of the winged-helix/forkhead transcription factors, has been well characterized as transcriptional repressor of effector cytokines like interleukin-2 (IL-2) [4] . This suppressor function depends not only on direct promoter occupancy but also on interactions with other proteins, including histone acetyltransferase and class II histone deacetylase [5] , runt-related transcription factor 1 (RUNX1) [6] and NFAT [7] . Besides this well-described negative impact on transcription, recent evidence accumulated that FOXP3 also positively modulates transcription. Many FOXP3-binding promoter regions in mice include FOXP3-induced genes, e.g. Nrp1, CTLA4, GITR and CD25 [8] [9] [10] .
Although FOXP3 expression in murine CD4 ϩ T cells specifically marks regulatory T cells, an important difference has become apparent recently between CD4
ϩ T cells of man and mouse.
Following T-cell receptor (TCR) activation, human effector CD4
ϩ [11] [12] [13] . [14] .
CD25 Ϫ T (Th) cells up-regulate FOXP3 protein similar to other markers of T-cell activation including CD25 and CTLA4, and produce effector cytokines like IL-2 and interferon-␥ despite the presence of FOXP3

It follows that specific high level of FOXP3 expression in human Treg cells requires exclusive control mechanisms to explain the qualitative and quantitative differences of FOXP3 expression between human activated Th and Treg cells or as suggested recently, a higher-order regulation
To gain new insights into the differential regulation of FOXP3, we used whole genome transcriptom analysis of resting and activated CD4
ϩ
CD25
hi Treg [15] . Thymic tissue was obtained from otherwise healthy children undergoing cardiac surgery (n ϭ 7, age range 4 days to 3 years) and freshly processed. Thymocytes were isolated as described recently [16] . [17] . 
Materials and methods
Cell isolation
Antibodies (Abs) and immunization
For immunostaining PE-, FITC-, APC-and CyChrom-conjugated mAbs against CD4 (RPA-T4), CD8 (53-6.7), CD25 (M-A251), CTLA4 (BNI3)
,
T-cell functional assays
GARP structural analysis
Described in detail in supplemental Experimental Procedures. (Fig. S1B) [20] . We used electron microscopy and 3D image reconstruction to confirm the horseshoe-shaped appearance of GARP ( Fig. 1D [21] . (Fig. 1E) .
GeneChip assays and microarray data analysis
and E).Whereas TLRs share a cytoplasmic Toll/IL-1 receptor domain, GARP does not contain such a welldefined signalling domain within its 14 aa short cytoplasmic tail. However, the four C-terminal amino acids Gln-Tyr-Lys-Ala of GARP exhibit homology to the PDZ (post-synaptic density protein-95, post-synaptic disc large and zona occludens-1) class II binding motif, a modular interaction domain
To confirm expression of GARP protein in human activated Treg cells, we immunized mice with bacterially expressed human GARP protein or a synthetic peptide GARP296-308, respectively, to generate anti-GARP specific mAbs. Immunoblot analysis using anti-GARP mAb 50G10 revealed GARP protein expression in activated Treg cells but not in alloantigen-specific Th cells (Fig. 1F). But unlike cell surface expression in epithelial 293 cells transfected with GARP using with the epitope specific anti-GARP296-308 mAb 272G6 (Fig. 1G), detection on Jurkat T cell tranduced with GARP nor on Treg cells was detected (data not shown). Even stimulation using PMA/ionomycin for 4 hrs, effectively up-regulating the early-induced gene CD83 that is differentially induced in Treg versus Th cells [22], did not let to detectable surface expression of GARP using mAb 272G6 on Treg cells. Because mAb 272G6 also did not detect surface expression on human platelets, which have been reported recently to have GARP surface expression [23], the respective GARP epitope recognized by mAb 272G6 might in some way be mask at least on human T cells and platelets. Moreover, the amount surface expression of GARP in 293 cells depended on the presence of an intact C-terminal PDZ domain, because mutation of the C-terminal Ala towards a Ser impaired protein expression of GARP (Fig. 1G). Thus, GARP represents an orphan TLR specifically induced in human CD4
Ectopic expression of GARP in human antigen-specific T h cells confers sustained expression of FOXP3
Flow-cytometry of ThGARP cells under resting conditions revealed sustained high levels of FOXP3 protein expression comparable to FOXP3-transduced allo-reactive Th cells and Treg cells (Fig. 2A). This was accompanied by up-regulation of the Treg-markers CD25, CTLA4, ␤-galactoside binding protein
LGALS3 [15] and CD27 [24] in ThGARP and ThFOXP3 cells, whereas CD33 (see below), GITR and CD83 [22] were not similarly affected (Fig. 2B) .
We (Fig. 3A) . In contrast, ThGARP cells revealed severe repression of IL-2 transcription similar to Treg and ThFOXP3 cells (Fig. 3A) .
further wanted to test whether TCR activation of ThGARP cells would enhance FOXP3 expression. As presented in Fig. 2C, antigen-specific stimulation using allogeneic EBV B cells and IL-2 profoundly increased FOXP3 as well as LGALS3 expression in Th cells that ectopically expressed GARP or FOXP3 but not ThGFP cells. Important to note, that the conversion of an effector towards a regulatory phenotype observed represents a process that needs repeated rounds of TCR stimulations before being established (data not shown). Thus, ectopic expression of GARP in antigen-specific Th cells modulated the TCR-dependent signalling of effector T cells towards the conversion into regulatory T cells including sustained expression of FOXP3 und up-regulation of
GARP induces a T reg -signature of transcriptional control
ThGARP cells exhibited a phenotype that resembled activated Treg cells. We, therefore, wanted to establish whether such cells would show also impaired IL-2 transcription like Treg cells. Following stimulation of ThGFP cells with anti-CD3/IL-2, transcription of IL-2 was effectively induced
We [15, 25] (Fig. S2A) [15, 25] , CTLA4, LAG3 [26] , CD28 [15] , CD47 [27] , CD62L, CD27 (TNFRSF7) [24] , TNFRSF4 (CD134) [28] , TNFRSF9 (CD137) [29] , IL1R2 [15] , LGMN [15] and DICER [30] ( Table S2 , Fig. 3B [33] . Although CD33 is predominantly expressed in Treg cells (Fig. 2B) (Fig. S3A) or GITR and CD83 (Fig. 2B) Table S2 . (Fig. 3F) (Fig. 4B) . Suppression was cell-contact dependent, as it was blocked by a transwell membrane (Fig. 4B) . Importantly, both, anergy and suppressor function, were more pronounced in ThGARP cells compared to ThFOXP3 cells.
further tested genes known to be up-regulated in Treg cells and alloantigen-specific Th cells transduced with FOXP3 using semi-quantitative RT-PCR including the endosomal cysteineprotease LGMN, the ubiquitin-like gene diubiquitin (UBD) and IL-1 receptor 2 (IL1R2)
. Similar to FOXP3-transduced Th cells, GARP-transduction led to the up-regulation of such genes
(C) Real-time RT-PCR analysis of KLF-2 expression in anti-CD3/IL-2 stimulated Th cells transduced with GARP, FOXP3 or GFP. Relative mRNA expression of ThGFP cells was arbitrarily set as 1 (upper panel). Real-time RT-PCR analysis of KLF-2 mRNA in Th cells transduced with LGALS3 and LGMN; Th cells transduced with GFP, GARP, and parental cells without transduction (ThGFP-) served as control (cell line ThB). Relative mRNA expression of ThGFP-cells was arbitrarily set as 1 (lower panel). (D) FOXP3 expressio5n in antigenspecific Th cells separated we transduced A5 hybridoma T cells, which express a GFP-reporter under control of a basal NFAT promoter described recently [34], with GARP, mutant GARP⌬PDZ or control vector. After stimulation with ionomycine for 2 and 4 hrs, flow-cytometry revealed a sever impairment of NFAT-dependent GFP induction
GARP confers regulatory function to human antigen-specific T h cells
The above results indicate that GARP is sufficient to cause Treglike phenotypic and transcriptional changes in antigen-specific Th cells. Because the hallmark of Treg cells is their anergic proliferative response and suppressor function, we stimulated ThGARP cells to assess their functional properties. Ectopic expression of GARP in alloantigen-specific Th cells severely reduced their proliferative capacity (Fig. 4A), which could be partially reversed by exogenous IL-2 (data not shown). Such an anergic proliferative response was also observed in ThFOXP3 cells but not in ThGFP control cells (Fig. 4A). Moreover, ThGARP cells acquired a strong suppressor activity equivalent to the activity found in Treg cells
Fig. 4 Anergy and suppressor function induced by overexpression of GARP in human alloantigen-specific Th cells. (A) Treg cells and Th cells as in Figs 1-3 were stimulated for proliferation using irradiated allogeneic EBV B cells (stim.); bkg. ϭ background proliferation. Proliferation was assessed at day 3 by measuring incorporation of H 3 -thymidin (cpm). (B) Treg and Th cells as in (A) were tested for suppressor function of alloantigen-stimulated ThGFP cells at a ratio of 1 to 1 either separated by a transwell membrane (no contact, upper panel) or without separation (cell contact, middle panel); lower panel represents induced ThGFP cell proliferation without the addition of a potential suppressor or control cell population. Proliferation was assessed at day 3. Similar results were obtained using antigen-specific Th cells as responder cells instead of ThGFP cells (Fig. S6B). (C) Single donor platelets as natural source of GARP ϩ cells was tested for suppressor function of alloantigen-stimulated Th cells at indicated ratios as in (B); addition of Th and Treg cells as in (B) at a ratio of 1:1 were included as negative and positive control of suppressor function, respectively.
To investigate a potential direct role of GARP in the suppression of Th cell proliferation, we used platelets as natural source of GARP
ϩ cells [23] in a suppressor assay as in Fig. 4 . No suppression of Th cell proliferation was observed (Fig. 4C) [15] Fig. 5A . This down-regulation was associated with concurrent down-regulation of FOXP3 mRNA (Fig. 5A) . This down-regulation of GARP and FOXP3 was associated with some phenotypic changes, including impaired induction of CD83 and CD27, both known to regulate FOXP3 [22, 35] 
with siRNA using a lentiviral vector system. Confirmation of FOXP3 expression, lack of IL-2 induction, anergy, and suppressor function of this Treg cell line is presented Fig. S4. Treg cells transduced with specific siRNA for GARP, FOXP3 or an irrelevant control were isolated by cell-sorting for GFP included as marker in the lentiviral vector. Quantitative real-time RT-PCR analysis of sorted transductants revealed that irrelevant siRNA did affect neither FOXP3 and GARP expression nor impaired regulatory function of Treg cells (data not shown). In contrast, GARP-specific siRNA mediated down-regulation of GARP in Treg cells (TregsiGARP) as demonstrated in
, suggesting an interrelated network of FOXP3-regulating systems in Treg cells, and down-regulation of CD25 (Fig. 5B). More importantly, TregsiGARP and TregsiFOXP3 cells revealed comparable impairments of their suppressor activity (Fig. 5C) and improvement of proliferative capacity in the presence of IL-2 (Fig. 5C). Together, these results demonstrate compellingly a positive feedback loop between GARP and FOXP3 in human Treg cells, which is an essential component of a higherorder regulation for the maintenance of the regulatory phenotype.
GARP represents a specific marker of activated CD4
ϩ CD25 hi -derived T reg cells [36] (Fig. S6) 
Natural Treg cells and TGF-␤-induced Treg cells differ in some aspects
. Identical results were obtained with five independent transductions of alloantigenspecific Th cell lines from three individual donors. Hence, GARP represents a receptor involved higher-order control of sustained expression of FOXP3 with the potential to convert diseaseassociated antigen-specific effector T towards regulatory T cells.
LGMN and LGALS3 are constituents of the GARP-FOXP3 feedback loop
Our previous results showed that LGALS3 and LGMN [15] were upregulated in alloantigen-specific Th cells transduced with FOXP3. Both proteins were also induced by GARP (Fig. 2B, Fig. S2 (Fig. 2B) . This suggests that LGALS3 acts down-stream of GARP, FOXP3 and LGMN. As serine-6 phosphorylation of LGALS3 has been reported to control its function [40] , we tested whether deletion of this caseine-kinase I site would affect its FOXP3-inducing capacity.
Analyses of FOXP3 expression in activated Th cells transduced with either wild-type or serine-to-alanine mutant
LGALS3 revealed the importance of serine-6, because the mutant LGALS3 did not induce FOXP3 (Fig. S7A) . 
To understand the impact of LGMN and LGALS3 on the regulation of GARP and FOXP3 we analysed our alloantigen-specific Th cells transduced with LGMN and LGALS3 for expression of GARP
and FOXP3. Analysis under resting conditions revealed that GARP protein expression was only minimally affected in ThLGMN and
ThLGALS3 cells (Fig. 1D) , while FOXP3 protein was obviously induced but not reaching the levels detected in ThGARP or Treg cells (Fig. 2A) . Levels of CD25, CTLA4 and CD33 in ThLGMN and ThLGALS3 cells did also not reach that observed in ThGARP and Treg cells (Fig. 2B) , whereas CD27 was obviously induced in ThLGMN similar to ThFOXP3 cells (Fig. 2B) . Similar to ThGARP and ThFOXP3 cells, LGMN and LGALS3 overexpression did not affect CD83 or GITR expression (Fig. 2B) .
Because activation of Th cells up-regulates expression of FOXP3, we tested ThLGMN and ThLGALS3 cells for expression of FOXP3, LGALS3 and GARP after antigen-specific stimulation. Activation of ThLGMN and ThLGALS3 cells clearly enhanced FOXP3, LGALS3, but not GARP protein expression (Figs 1E and 2C). Nevertheless, levels of FOXP3 and LGALS3 never reached levels observed in ThGARP and Treg cells. This suggests an involvement of LGMN and LGALS3 in the GARP-FOXP3 feedback loop mainly following T-cell activation.
LGMN and LGALS3 induce a partial T reg -signature (Fig. 3A) . Similarly, only minimal induction of IL1R2 and UBD mRNA (Fig. S2A) was observed, indicating partial FOXP3-dependent transcriptional control. Interestingly, although FOXP3 and GARP mRNA was highly elevated in ThLGMN and ThLGALS3 cells (Fig. S3B) , the presence of such levels of specific mRNA was not sufficient to induce Treglike protein expression (Figs 1D and 2B) , suggesting post-transcriptional control of GARP and FOXP3 expression. (Fig. S3A) . In contrast, KLF-2 induction was observed only in ThLGALS3 but not ThLGMN cells (Fig. 3C) . Because serine-6 phosphorylation of LGALS3 was an essential prerequisite to induce FOXP3, we tested the effects of mutant LGALS3 on the expression of GARP and LGMN. Under resting and activated conditions, the mutant LGALS3 was unable to induce GARP and LGMN, corroborating the proposed interrelation of LGALS3 with these genes via FOXP3 (Fig. S7B) . Interestingly, KLF-2 was not affected by the serine-6 mutation of LGALS3, suggesting that LGALS3 also regulates some gene expression down-stream of FOXP3 independent of its phosphorylation (Fig. S7B) .
We extended our analysis to the transcriptional control of genes of the Treg-signature. Quantitative RT-PCR revealed repression of IL-2 transcription in ThLGMN and ThLGALS3 cells
In line with the lower levels of FOXP3 and GARP expression, genes of the extended Treg-signature were not up-regulated in ThLGMN and ThLGALS3 cells. These included RYR-1, HPGD and CPE (Fig. S3A). A further difference represented the up-regulation of IL7R observed only in ThLGMN cells
As expected, the functional changes observed in ThLGMN and ThLGALS3 cells were only minor (Fig. 4A) and no significant suppressive activity was observed (Fig. 4B) [43] . In lymphoid organs of mice, the expression of GARP was restricted to endothelial and megakaryocytic cells [23, 43] , suggesting a role in coagulation that has recently been confirmed in a coagulation model in zebrafish [44] . [45] . These authors showed that transduction of GARP or GARP without the cytoplasmic tail were equally efficient in partially inducing FOXP3 in human T cells [45] [49] , because both factors are involved in the control of FOXP3 transcription in human T cells [50] . As expected, the impaired induction of FOXP3 by the mutant LGALS3 was accompanied by the inability to induce GARP and LGMN. Although serine-6 phosphorylation of LGALS3 has been described as important checkpoint in the control of LGALS3, some phosphorylation independent unique functions have also been reported [40] . In line with that, the serine-6 mutant LGALS3 had nearly the same effect on the expression of KLF-2, suggesting that KLF-2 might be regulated by FOXP3 via LGALS3 independent on its serine-6 phosphorylation.
In 
